Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (Unaudited) Selected Quarterly Financial Data (Note)

v2.4.1.9
Selected Quarterly Financial Data (Unaudited) Selected Quarterly Financial Data (Note)
12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Text Block]
. Selected Quarterly Financial Data (Unaudited)
The following table presents the Company’s unaudited quarterly financial data for each of the eight quarters in the period ended December 31, 2014. In management’s opinion, this information has been presented on the same basis as the audited consolidated financial statements included in a separate section of this report, and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited consolidated financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.
 
Year Ended December 31, 2014
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
(in thousands)
Net revenue
$
32,501

 
$
35,592

 
$
32,541

 
$
32,478

Gross profit
$
20,053

 
$
22,246

 
$
19,909

 
$
19,750

Net income (loss)
$
(862
)
 
$
(612
)
 
$
(3,205
)
 
$
(2,362
)
Net income (loss) per share:
 
 
 
 
 
 
 
Basic
$
(0.02
)
 
$
(0.02
)
 
$
(0.09
)
 
$
(0.06
)
Diluted
$
(0.02
)
 
$
(0.02
)
 
$
(0.09
)
 
$
(0.06
)
 
Year Ended December 31, 2013
 
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
(in thousands)
Net revenue
$
26,534

 
$
29,773

 
$
31,765

 
$
31,574

Gross profit
$
16,712

 
$
17,296

 
$
19,831

 
$
19,124

Net income (loss)
$
(2,300
)
 
$ (2,904)1

 
$ (4,882)2

 
$
(2,647
)
Net income (loss) per share:
 
 
 
 
 
 
 
Basic
$
(0.07
)
 
$
(0.09
)
 
$
(0.14
)
 
$
(0.08
)
Diluted
$
(0.07
)
 
$
(0.09
)
 
$
(0.14
)
 
$
(0.08
)

 
1 
Includes an impairment charge of $1.1 million related to the remaining net book value of production masks that were previously capitalized, but for which future use is no longer expected.
2 
Includes a one-time payment of $1.25 million to Silicon Labs in connection with the settlement agreement.